Puma Biotechnology Inc (NASDAQ:PBYI)
| 2.78 Delayed Data As of Jul 01 |  -0.07 / -2.46%Today’s Change | 1.60 Today|||52-Week Range 9.48 | -8.55% Year-to-Date |
Latest PBYI News | Press Releases
No recent news for Puma Biotechnology Inc.
Today’s Trading
| Previous close | 2.85 |
| Today’s open | 2.84 |
| Day’s range | 2.70 - 2.89 |
| Volume | 18,568 |
| Average volume (3 months) | 491,641 |
| Market cap | $128.6M |
Data as of 3:59pm ET, 07/01/2022
Growth & Valuation
| Earnings growth (last year) | +52.72% |
| Earnings growth (this year) | +98.79% |
| Earnings growth (next 5 years) | +33.70% |
| Revenue growth (last year) | +12.46% |
| P/E ratio | NM |
| Price/Sales | 0.49 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| EPIXESSA Pharma Inc | -0.33 | -10.48% |
| MNOVMediciNova Inc | -0.05 | -1.98% |
| CTMXCytomX Therapeutics ... | +0.03 | +1.64% |
| CTXRCitius Pharmaceutica... | -0.02 | -2.10% |
Data as of 3:59pm ET, 07/01/2022
Financials
| Next reporting date | August 11, 2022 |
| EPS forecast (this quarter) | $0.01 |
| Annual revenue (last year) | $253.2M |
| Annual profit (last year) | -$29.1M |
| Net profit margin | -11.51% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Los Angeles, California |
Forecasts
